GSK slims portfolio with sale of rare disease gene therapy drugs
The company divests its rare disease gene therapy drugs to Orchard Therapeutics
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Sanofi to invest 350 million euros in Canada vaccine facility
The new facility would allow its Sanofi Pasteur division to meet the growing demand of five-component acellular pertussis (5-acP)…
Strides Shasun arm gets US FDA nod for allergy relief drug
The drug will be manufactured at its oral dosage facility at Bengaluru and will be marketed by Strides Pharma in the US
Sundyota Numandis launches anti-diarrhoea probiotic
The company has entered into a strategic partnership with Italian firm Probiotical
Novartis Group appoints Milan Paleja as Country President, Novartis in India
Paleja is a graduate from Bombay University and holds a Cost Accountants degree from the Institute of Cost Accountants of India
Eisai commences sales of Biogen’s Multiple Sclerosis treatment portfolio in India
The sale agreement is based on collaboration with Biogen
DRL gets EIR from US FDA
The EIR is received for DRL's Cuernavaca plant in Mexico
Dr Reddy's Laboratories (DRL) has received establishment inspection…
Merck’s KEYTRUDA monotherapy trial meets primary endpoint
Treatment with KEYTRUDA resulted in significantly longer OS than platinum-based chemotherapy in patients with a PD-L1 tumour…
analytica Anacon India and India Lab Expo
Messe Muenchen India announced a regional edition of analytica Anacon India and India Lab Expo, the market leading trade fairs for…
Mumbai to host analytica Anacon India and India Lab Expo in April 2018
The trade fair is scheduled for April 25-26, 2018 at Bombay Exhibition Centre